Almac Diagnostic Services Awarded Olink™ Certified Service Provider Status, Expanding Proteomics Capabilities for Biopharma Clients

Almac Diagnostic Services, a global leader in precision medicine and biomarker-driven clinical trial solutions, today announces that it has been awarded Certified Service Provider (CSP) status by Olink^TM, part of Thermo Fisher Scientific). This certification enables Almac Diagnostic Services to offer multiple Olink proteomics solutions to biopharmaceutical partners, further strengthening its multi‑omic capabilities across biomarker discovery, translational research and clinical development.

As an Olink Certified Service Provider, Almac Diagnostic Services delivers gold‑standard, high‑sensitivity proteomics services using Olink’s industry‑leading Proximity Extension Assay^TM (PEA) technology. The Almac service offering includes Olink^TM Target 48, Olink ^TM Target 96, and Olink ^TM Reveal panels, supporting studies ranging from focused pathway analysis to high‑throughput, large‑scale protein profiling.

The service is delivered through Almac’s CLIA‑certified and CAP‑accredited global laboratories, supported by ISO‑aligned quality systems, ensuring robust, reproducible data generation suitable for biopharma research and regulated clinical programmes.

Almac provides end‑to‑end proteomics support, including study design, sample preparation, library preparation, qPCR and NGS sequencing, data QC and advanced bioinformatics analysis. Secure sample storage and future re‑analysis options are also available, enabling long‑term value from precious clinical samples.

“Almac Diagnostic Services is dedicated to expanding our Multi-Omic Services portfolio, in response to client needs. Incorporating innovative technologies like Olink Proteomic panels helps to expand our offering for biopharma clients to include both molecular and proteomic solutions that are required for complex biomarker drug development programmes. We are also able to offer IHC,  single cell and spatial transcriptomics as part of Almac’s overall offering.” said Laura Knight, VP of Genomic Services, Almac Diagnostic Services.

For more information about Almac Diagnostic Services’ proteomics offerings, visit:
www.almacgroup.com/diagnostics/proteomics-service